{"transactions":[{"id":969182,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-15T16:15:06.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":0.3756,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001240499-25-000004","document":"form4-12152025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000124049925000004/form4-12152025_041201.xml","form_type":"4"}},{"id":1332134,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T16:15:20.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029289","document":"form4-12132024_041213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000141588924029289/form4-12132024_041213.xml","form_type":"4"}},{"id":1423153,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T17:35:52.000Z","date":"2024-08-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":973,"price":1.52,"value":1478.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon the consummation of the merger (the \"Merger\") pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 25, 2024, by and among Agile Therapeutics, Inc. (the \"Company\"), Insud Pharma, S.L. (\"Insud\"), and Exeltis Project, Inc., a Delaware corporation and indirect, wholly owned subsidiary of Insud (\"Merger Sub\"), 973 shares of Common Stock were converted into the right to receive into the right to receive a cash payment of $1.52 (the \"Merger Consideration\") per share of Common Stock, for an aggregate of $1,479, equal to the product of (x) the Merger Consideration, multiplied by (y) the total number of shares of Common Stock owned by the reporting person"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-092940","document":"tm2422466-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465924092940/tm2422466-5_4seq1.xml","form_type":"4"}},{"id":1691539,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T17:09:19.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-24-000459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919124000459/doc4.xml","form_type":"4"}},{"id":1708976,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T17:01:39.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919123058807/doc4.xml","form_type":"4"}},{"id":1860331,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T17:08:27.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":1065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 8, 2023 and vests in full on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":1065,"derivative":{"exercise_price":3.58,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":1065},"source":{"system":"sec-edgar","filing":"0000929638-23-001706","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000092963823001706/form4.xml","form_type":"4"}},{"id":1860330,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-09T17:08:27.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 8, 2023, which will vest and be settled in common stock on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 10, 2023 the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":974,"source":{"system":"sec-edgar","filing":"0000929638-23-001706","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000092963823001706/form4.xml","form_type":"4"}},{"id":2186806,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-08-12T17:10:38.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023."}],"balance_after":20500,"derivative":{"exercise_price":0.312,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-22-045648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919122045648/doc4.xml","form_type":"4"}},{"id":2235702,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-10T16:49:08.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 9, 2022 and vests in full on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":807,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":807},"source":{"system":"sec-edgar","filing":"0001104659-22-070184","document":"tm2218213-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465922070184/tm2218213-7_4seq1.xml","form_type":"4"}},{"id":2235701,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T16:49:08.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2022, which will vest and be settled in common stock on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 26, 2022, the Issuer completed a one-for-forty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":1952,"source":{"system":"sec-edgar","filing":"0001104659-22-070184","document":"tm2218213-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465922070184/tm2218213-7_4seq1.xml","form_type":"4"}},{"id":2629110,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-07-20T17:04:13.000Z","date":"2021-07-19","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over a 12 month period in equal, monthly installments, ending July 19, 2022."}],"balance_after":20500,"derivative":{"exercise_price":2.75,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-21-047405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919121047405/doc4.xml","form_type":"4"}},{"id":2673685,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-10T19:11:08.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":29905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 8, 2021 and vests in full on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":29905,"derivative":{"exercise_price":1.53,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":29905},"source":{"system":"sec-edgar","filing":"0001104659-21-079619","document":"tm2119345-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465921079619/tm2119345-6_4seq1.xml","form_type":"4"}},{"id":2673684,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-10T19:11:08.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":24510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 8, 2021, which will vest and be settled in common stock on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":51296,"source":{"system":"sec-edgar","filing":"0001104659-21-079619","document":"tm2119345-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465921079619/tm2119345-6_4seq1.xml","form_type":"4"}},{"id":3049743,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T17:00:59.000Z","date":"2020-08-20","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vested over a 12 month period, in equal, quarterly installments, ending May 16, 2020."}],"balance_after":13971,"derivative":{"exercise_price":1.48,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-20-047960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919120047960/doc4.xml","form_type":"4"}},{"id":3049742,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T17:00:59.000Z","date":"2020-08-20","kind":"exercise","acquired":true,"shares":75000,"price":1.48,"value":111000.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001209191-20-047960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919120047960/doc4.xml","form_type":"4"}},{"id":3067136,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-05T16:37:53.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over a 12 month period in equal, quarterly installments, ending August 3, 2021."}],"balance_after":22500,"derivative":{"exercise_price":1.72,"expiration_date":"2030-08-03","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-20-045128","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919120045128/doc4.xml","form_type":"4"}},{"id":3113186,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-11T17:20:40.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":45212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 9, 2020 and vests in three equal annual installments beginning on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through each vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during each respective year of board service."}],"balance_after":45212,"derivative":{"exercise_price":2.8,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":45212},"source":{"system":"sec-edgar","filing":"0001104659-20-072483","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465920072483/a4.xml","form_type":"4"}},{"id":3113185,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T17:20:40.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":26786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2020, which will vest and be settled in common stock in three equal annual installments beginning on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through each vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during each respective year of board service."}],"balance_after":26786,"source":{"system":"sec-edgar","filing":"0001104659-20-072483","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465920072483/a4.xml","form_type":"4"}},{"id":3197735,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-03-23T16:43:42.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":2.67,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-20-020656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919120020656/doc4.xml","form_type":"4"}},{"id":3215456,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-03-11T17:54:48.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":29271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in or in connection with the merger of Foamix Pharmaceuticals Ltd.  (\"Foamix\"), and Giants Merger Subsidiary Ltd., a direct, wholly owned subsidiary of Menlo Therapeutics Inc. (\"Menlo\"), in exchange for Foamix equity securities, as further described in the Form 4 filed by the Reporting Person on the date hereof in respect of the Reporting Person's interests in Foamix equity securities. The Reporting Person also received certain contingent stock rights which are subject to the terms and conditions of the contingent stock rights agreement, dated as of March 9, 2020, by and between American Stock Transfer & Trust Company, LLC and Menlo, or related contractual interests, either of which may entitle the Reporting Person to certain additional Menlo equity securities or the adjustment of certain Menlo equity securities, all as further described in that Current Report on Form 8-K filed by Menlo with the Securities and Exchange Commission on March 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 16, 2020."}],"balance_after":29271,"derivative":{"exercise_price":4.5,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":29271},"source":{"system":"sec-edgar","filing":"0001209191-20-018220","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919120018220/doc4.xml","form_type":"4"}},{"id":3215455,"issuer":{"id":150527,"kind":"organization","name":"Foamix Pharmaceuticals Ltd.","symbol":"FOMX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2020-03-11T17:36:48.000Z","date":"2020-03-09","kind":"disposition_to_issuer","acquired":false,"shares":49412,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 9, 2020 (the \"Closing Date\"), pursuant to the Agreement and Plan of Merger, dated as of November 10, 2019, as amended on December 4, 2019 (as amended, the \"Merger Agreement\"), by and among Menlo Therapeutics Inc., a Delaware corporation (\"Menlo\"), Foamix Pharmaceuticals Ltd., a company organized under the laws of Israel (\"Foamix\"), and Giants Merger Subsidiary Ltd., a direct, wholly owned subsidiary of Menlo (\"Merger Sub\"), Merger Sub merged with and into Foamix, with Foamix surviving as a wholly owned subsidiary of Menlo (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each ordinary share, par value NIS 0.16 per share, of Foamix (\"Foamix Shares\") issued and outstanding immediately prior to the Effective Time was deemed transferred under Israeli law to Menlo in exchange for the right to receive (i) 0.5924 shares (the \"Exchange Ratio\") of common stock of Menlo (\"Menlo Common Stock\") and (ii) one contingent stock right (continued in footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(a \"CSR\"; and collectively, the \"CSRs\") which are subject to the terms and conditions of the contingent stock rights agreement, dated as of March 9, 2020, by and between American Stock Transfer & Trust Company, LLC and Menlo (the \"CSR Agreement\"), as further described in that Current Report on Form 8-K filed by Menlo with the Securities and Exchange Commission on March 9, 2020 (collectively, the \"Merger Consideration\"). The closing price of a share of Menlo Common Stock on March 6, 2020, the last trading day before the Effective Time, was $4.15. No fractional share of Menlo Common Stock was issued in the Merger, and Foamix shareholders received cash in lieu of fractional shares, as specified in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each option to purchase a Foamix Share (a \"Foamix Option\") was converted into an option to purchase Menlo Common Stock (an \"Adjusted Option\") with the same terms and conditions as applied to the Foamix Option immediately prior to the Effective Time; however, the Adjusted Option covers a number of shares of Menlo Common Stock equal to the product of (i) the number of Foamix Shares subject to the Foamix Option immediately prior to the Effective Time and (ii) the Exchange Ratio, and has an exercise price per share equal to the quotient of (i) the exercise price per Foamix Share subject to such Foamix Option immediately prior to the Effective Time divided by (ii) the Exchange Ratio. If the CSRs become convertible, then the Menlo board of directors will make equitable adjustments to the exercise price per share of and the number of shares of Menlo Common Stock that are subject to Adjusted Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 16, 2020."}],"balance_after":0,"derivative":{"exercise_price":2.66,"expiration_date":"2029-05-16","underlying":"Ordinary Shares","underlying_shares":49412},"source":{"system":"sec-edgar","filing":"0001209191-20-018190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919120018190/doc4.xml","form_type":"4"}},{"id":3518208,"issuer":{"id":150527,"kind":"organization","name":"Foamix Pharmaceuticals Ltd.","symbol":"FOMX"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-05-20T18:27:08.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":49412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each option represents a contingent right to purchase one ordinary share of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 16, 2020."}],"balance_after":49412,"derivative":{"exercise_price":2.66,"expiration_date":"2029-05-16","underlying":"Ordinary Shares","underlying_shares":49412},"source":{"system":"sec-edgar","filing":"0001209191-19-031522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919119031522/doc4.xml","form_type":"4"}},{"id":4019536,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-02T19:13:43.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":1424,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":43417,"source":{"system":"sec-edgar","filing":"0001683168-18-000575","document":"barbari_f4-030118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316818000575/barbari_f4-030118.xml","form_type":"4"}},{"id":4111007,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-01-03T21:39:26.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":17211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a bonus for services and vests immediately."}],"balance_after":41993,"source":{"system":"sec-edgar","filing":"0001683168-18-000036","document":"barbari_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316818000036/barbari_f4.xml","form_type":"4"}},{"id":4145935,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-12-01T16:39:47.000Z","date":"2017-11-29","kind":"grant","acquired":true,"shares":13944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer as well as an annual grant pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":24782,"source":{"system":"sec-edgar","filing":"0001683168-17-003203","document":"barbari_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316817003203/barbari_f4.xml","form_type":"4"}},{"id":4221433,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-08-30T18:53:15.000Z","date":"2017-08-29","kind":"grant","acquired":true,"shares":880,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":10838,"source":{"system":"sec-edgar","filing":"0001683168-17-002258","document":"barbari_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316817002258/barbari_f4.xml","form_type":"4"}},{"id":4297875,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-06-01T08:29:52.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":754,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":9958,"source":{"system":"sec-edgar","filing":"0001683168-17-001456","document":"barbari_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316817001456/barbari_frm4.xml","form_type":"4"}},{"id":4410678,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & CFO"}}],"security":"Common Stock","published_at":"2017-03-03T00:07:31.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":7317,"price":10.6,"value":77560.2,"ownership":{"direct":true},"balance_after":40323,"source":{"system":"sec-edgar","filing":"0001061983-17-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000019/edgardoc.xml","form_type":"4"}},{"id":4410677,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Finance & CFO"}}],"security":"Common Stock","published_at":"2017-03-03T00:07:31.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":18750,"price":0.001,"value":18.75,"ownership":{"direct":true},"balance_after":47640,"source":{"system":"sec-edgar","filing":"0001061983-17-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000019/edgardoc.xml","form_type":"4"}},{"id":4408879,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-03-02T16:06:07.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":710,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":9204,"source":{"system":"sec-edgar","filing":"0001683168-17-000477","document":"barbari_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316817000477/barbari_f4.xml","form_type":"4"}},{"id":4408878,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-03-02T16:06:07.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as an annual grant pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":8494,"source":{"system":"sec-edgar","filing":"0001683168-17-000477","document":"barbari_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316817000477/barbari_f4.xml","form_type":"4"}},{"id":4538569,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2016-11-30T16:57:37.000Z","date":"2016-11-29","kind":"grant","acquired":true,"shares":1035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":6244,"source":{"system":"sec-edgar","filing":"0001683168-16-000813","document":"barbari_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316816000813/barbari_frm4.xml","form_type":"4"}}]}